Skip to main content

Neuromodulation Society honors Hacker’s Parkinson’s research

Dec. 6, 2018, 10:20 AM

 

by Tom Wilemon

Mallory Hacker, PhD, research assistant professor of Neurology, is the 2019 recipient of the Kumar New Investigator Award from the North American Neuromodulation Society.

Mallory Hacker, PhD

The society chose Hacker because of her research into deep brain stimulation (DBS) for early-stage Parkinson’s disease. She is the lead author of a study published in June in Neurology that suggested DBS administered to patients with very early-stage Parkinson’s disease slowed the progression of rest tremor.

“This encouraging finding must now be tested in a large, multicenter trial,” Hacker said.

“It is truly an honor to receive this award. This recognition speaks to the importance of the pioneering research conducted by Vanderbilt researchers who led the pilot trial of DBS in early-stage Parkinson’s disease — David Charles, MD, and Peter Konrad, MD, PhD.”

She and other Vanderbilt University Medical Center researchers are continuing to study DBS as an earlier intervention for Parkinson’s. The National Institute of Neurological Disorders and Stroke, a division of the National Institutes of Health, awarded a $275,000 grant to Hacker this year to conduct a longitudinal study of Parkinson’s disease patients who underwent DBS a decade ago as participants in the first and only clinical trial of DBS as a treatment for early-stage disease. The research has also received $50,000 in support from the American Parkinson Disease Association.

The U.S. Food and Drug Administration has approved Vanderbilt to lead a Phase III, multicenter, prospective, randomized clinical trial to evaluate the safety and efficacy of DBS in early-stage Parkinson’s disease.

Recent Stories from VUMC News and Communications Publications

Sharon Seibert is among the more than 5,000 patients who have received a stem cell transplant at Vanderbilt-Ingram Cancer Center, which has one of the best survival rates in the nation and is at the forefront of new cellular therapies.

Momentum

Sharon Seibert is among the more than 5,000 patients who have received a stem cell transplant at Vanderbilt-Ingram Cancer Center, which has one of the best survival rates in the nation and is at the forefront of new cellular therapies.

The first few minutes of Charlie’s life were a blur, as a team of doctors and nurses at VUMC worked to resuscitate him and stabilize his heart rate. He was then transferred to the Neonatal Intensive Care Unit at Monroe Carell Jr. Children’s Hospital at Vanderbilt.

Hope

The first few minutes of Charlie’s life were a blur, as a team of doctors and nurses at VUMC worked to resuscitate him and stabilize his heart rate. He was then transferred to the Neonatal Intensive Care Unit at Monroe Carell Jr. Children’s Hospital at Vanderbilt.

Tucked away in a Vanderbilt conference room, 36 adults huddle over Lego pieces. Eleven teams have been assigned to assemble multicolored Legos using the written directions included in the packet. The result should be a Frankenstein figure.

Vanderbilt Nurse

Tucked away in a Vanderbilt conference room, 36 adults huddle over Lego pieces. Eleven teams have been assigned to assemble multicolored Legos using the written directions included in the packet. The result should be a Frankenstein figure.

Marissa Benchea has CF, and she is one of hundreds of thousands of adults not only surviving but thriving with a chronic childhood disease.

Vanderbilt Medicine

Marissa Benchea has CF, and she is one of hundreds of thousands of adults not only surviving but thriving with a chronic childhood disease.

more